Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
 9 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Cash Flows (Used In)/From Operating Activities    
NET INCOME $ 307,117,000 $ 90,160,000
Net income from discontinued operations (3,656,000) 12,988,000
Net income/(loss) from continued operations 310,773,000 77,172,000
Adjustments to reconcile net income (used in)/from operating activities:    
Depreciation and amortization 2,433,000 2,109,000
Noncash lease expense 2,344,000 2,094,000
Change in deferred taxes (2,508,000) 1,485,000
Stock compensation expense 5,635,000 57,000
Share based payment 0 517,000
Unrealized (gain)/loss on trading securities (5,487,000) (5,680,000)
Net change in accrued interest (24,664,000) (392,000)
Allowances for receivables 615,000 1,573,000
Changes in operating assets and liabilities:    
Lease liabilities (2,613,000) (1,873,000)
Trading securities (358,257,000) (37,819,000)
Brokerage and other receivables (143,118,000) 52,407,000
Other assets (9,680,000) (1,289,000)
Securities sold, not yet purchased – at fair value 5,979,000 9,078,000
Customer liabilities (230,970,000) 336,882,000
Current income tax liability 6,380,000 1,123,000
Trade payables 28,750,000 10,824,000
Other liabilities (346,000) (174,000)
Net cash flows (used in)/from operating activities from continuing operations (414,734,000) 448,094,000
Net cash flows (used in)/from operating activities from discontinued operations (222,901,000) 156,483,000
Net cash flows (used in)/from operating activities (637,635,000) 604,577,000
Cash Flows (Used In)/From Investing Activities    
Purchase of fixed assets (4,066,000) (1,011,000)
Proceeds from sale of fixed assets 175,000 7,000
Loans purchased from microfinance organization (29,020,000) 0
Loans sold to microfinance organization 6,828,000 0
Loans issued (11,946,000) 122,000
Proceeds from sale of available-for-sale securities, at fair value 0 6,437,000
Consideration paid for Zerich Capital Management 0 (7,110,000)
Consideration paid for Prime Executions 0 (2,500,000)
Consideration paid for Freedom Bank KZ 0 (53,097,000)
Cash, cash equivalents and restricted cash received from acquisitions 0 157,533,000
Net cash flows (used in)/from investing activities from continuing operations (38,029,000) 100,381,000
Net cash flows (used in)/from investing activities from discontinued operations (2,790,000) (1,102,000)
Net cash flows (used in)/from investing activities (40,819,000) 99,279,000
Cash Flows From Financing Activities    
Proceeds from securities repurchase agreement obligations 270,146,000 (1,511,000)
Proceeds from issuance of debt securities 13,000,000 3,554,000
Repurchase of debt securities (10,104,000) (8,186,000)
Net change in bank customer deposits 83,448,000 6,555,000
Proceeds from loans received 0 2,423,000
Exercise of options 119,000 118,000
Net cash flows from/(used in) financing activities from continuing operations 356,609,000 2,953,000
Net cash flows from/(used in) financing activities from discontinued operations 37,982,000 193,788,000
Net cash flows from financing activities 394,591,000 196,741,000
Effect of changes in foreign exchange rates on cash and cash equivalents from continuing operations (5,100,000) (1,050,000)
Effect of changes in foreign exchange rates on cash and cash equivalents from discontinued operations 13,695,000 4,837,000
NET CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH (275,268,000) 904,384,000
Cash, cash equivalents and restricted cash, beginning of period from continuing operations 658,708,000 76,820,000
Cash, cash equivalents and restricted cash, beginning of period from discontinued operations 559,385,000 110,361,000
Cash, cash equivalents and restricted cash, beginning of period 1,218,093,000 187,181,000
Cash, cash equivalents and restricted cash, end of period from discontinued operations 379,724,000 475,298,000
Cash, cash equivalents and restricted cash end of period from continuing operations 563,101,000 616,267,000
Cash, cash equivalents and restricted cash, end of period 942,825,000 1,091,565,000
Supplemental non-cash disclosures:    
Cash and cash equivalents 146,358,000 155,376,000
Restricted cash 416,743,000 460,891,000
Total cash, cash equivalents and restricted cash from continuing operations shown as in the statement of cash flows $ 563,101,000 $ 616,267,000